Patent · US Active

Trioxolane and related stabilized oxygen molecules based treatment product

US8901324B2 · kind B2 · utility

1Cited by
1References
17Claims
0Family size

Inventor

Key dates

Filing dateMay 14, 2013
Grant dateDec 2, 2014
Priority date
Expiry dateMay 14, 2033

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61Q19/08
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A treatment product including trioxolanes or related stabilized oxygen molecules. Just as oxidation is a somewhat violent electron transfer that results in amino acid malformation, only a molecule with similar electron attraction potential, another oxygen species in the form of a stabilized trioxolane or equivalent, can reverse such damage in most cases. The human body has the ability to fix such oxidation on its own, but this ability declines with age and excess damage. The treatment product described herein including trioxolanes, assists the body in this natural process. The result is reduction of inflammation, aging, and other conditions of the human body.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.